Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP) — H001-A2

Allergic Skin Reaction Clinical Trial

Official title:
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test

Status Completed

Clinical Trial Summary

This study is designed to evaluate the allergenicity of Amphadase® in healthy volunteers using an intradermal skin test.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Allergic Skin Reaction

Clinical Trial Details

NCT number	NCT01689363
Study type	Interventional
Source	Amphastar Pharmaceuticals, Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	September 2012
Completion date	December 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01425619` - The Effect of Medical Clowns and Topical Anesthetic Cream on Pain and Anxiety in Children Undergoing Allergy Skin Tests	N/A
Completed	`NCT04327752` - Skin Adverse Reactions Occuring in Children Treated by Biotherapy for Chronic Inflammatory Disease
Not yet recruiting	`NCT05533385` - Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts Standardisation.	N/A
Not yet recruiting	`NCT05532566` - Quercus Ilex and Quercus Robur Allergen Extracts Standardisation	N/A
Recruiting	`NCT06271993` - SPT for Sensitization of Collagen Dressing	N/A